• Explore /
  • Poster
  • / Effect of sulfasalazine (SSZ) on cancer stem-like cells (CSCs) via inhibiting xCT signal pathway: Phase 1 study in patients with gastric cancer (EPOC 1205).

Effect of sulfasalazine (SSZ) on cancer stem-like cells (CSCs) via inhibiting xCT signal pathway: Phase 1 study in patients with gastric cancer (EPOC 1205).

Abstract Poster

Authors

Kohei Shitara

Kohei Shitara

National Cancer Center Hospital East, Kashiwa, Japan

Kohei Shitara , Shunji Takahashi , Takako Eguchi Nakajima , Shuichi Hironaka , Osamu Nagano , Chiyo K. Imamura , Miki Fukunani , Hiromi Hasegawa , Akihiro Sato , Atsushi Ohtsu , Hideyuki Saya , Toshihiko Doi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics - Clinical Pharmacology and Experimental Therapeutics

Track

Developmental Therapeutics

Sub Track

Cancer Stem Cell Pathway

Clinical Trial Registration Number

UMIN000010254

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr 2545)

DOI

10.1200/jco.2014.32.15_suppl.2545

Abstract #

2545

Poster Bd #

8

Abstract Disclosures

Similar Posters

First Author: Wang Yk

First Author: Antonio Jimeno

First Author: Jeffrey R. Infante

First Author: Laura Williams Goff